Antiretroviral Therapy, Highly Active
"Antiretroviral Therapy, Highly Active" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.
| Descriptor ID |
D023241
|
| MeSH Number(s) |
E02.319.310.075
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antiretroviral Therapy, Highly Active".
Below are MeSH descriptors whose meaning is more specific than "Antiretroviral Therapy, Highly Active".
This graph shows the total number of publications written about "Antiretroviral Therapy, Highly Active" by people in this website by year, and whether "Antiretroviral Therapy, Highly Active" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 2 | 2 | 4 |
| 2003 | 7 | 2 | 9 |
| 2004 | 0 | 4 | 4 |
| 2005 | 3 | 7 | 10 |
| 2006 | 1 | 2 | 3 |
| 2007 | 2 | 2 | 4 |
| 2008 | 5 | 4 | 9 |
| 2009 | 5 | 3 | 8 |
| 2010 | 3 | 3 | 6 |
| 2011 | 4 | 5 | 9 |
| 2012 | 3 | 2 | 5 |
| 2013 | 5 | 3 | 8 |
| 2014 | 5 | 6 | 11 |
| 2015 | 1 | 2 | 3 |
| 2016 | 4 | 9 | 13 |
| 2017 | 52 | 93 | 145 |
| 2018 | 55 | 73 | 128 |
| 2019 | 15 | 26 | 41 |
| 2020 | 4 | 9 | 13 |
| 2021 | 0 | 5 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Antiretroviral Therapy, Highly Active" by people in Profiles.
-
ACE2, TMPRSS2, and L-SIGN Expression in Placentae From HIV-Positive Pregnancies Exposed to Antiretroviral Therapy-Implications for SARS-CoV-2 Placental Infection. J Infect Dis. 2021 Dec 08; 224(Supplement_6):S631-S641.
-
Stakeholder efforts to mitigate antiretroviral therapy interruption among people living with HIV during the COVID-19 pandemic in China: a qualitative study. J Int AIDS Soc. 2021 09; 24(9):e25781.
-
Psychosocial interventions for improving engagement in care and health and behavioural outcomes for adolescents and young people living with HIV: a systematic review and meta-analysis. J Int AIDS Soc. 2021 08; 24(8):e25741.
-
Exploring the challenges of women taking antiretroviral treatment during the COVID-19 pandemic lockdown in peri-urban Harare, Zimbabwe. Int J Gynaecol Obstet. 2021 Aug; 154(2):220-226.
-
Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV. Lancet HIV. 2021 06; 8(6):e317-e318.
-
HIV in the Amazon's indigenous populations. Lancet HIV. 2021 05; 8(5):e253-e254.
-
INPACVIH: tackling HIV in Peru's indigenous communities. Lancet HIV. 2021 05; 8(5):e255.
-
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy. Ann Intern Med. 2021 04; 174(4):581-582.
-
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy. Ann Intern Med. 2021 04; 174(4):580-581.
-
The potential effect of COVID-19-related disruptions on HIV incidence and HIV-related mortality among men who have sex with men in the USA: a modelling study. Lancet HIV. 2021 04; 8(4):e206-e215.